Acute bacterial rhinosinusitis. Do we always need antibiotics?


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Background. Treatment of patients with acute bacterial rhinosinusitis (ABR) is an urgent and unresolved problem: there is a widespread prevalence and increase in the resistance of pathogens due to irrational, repeated courses of antibiotic therapy, especially in cases of mild rhinosinusitis. In this regard, it seems relevant to study the possibilities of alternative treatment, without the use of antibiotics. Objective. Evaluation of the effectiveness of monotherapy with Sinuforte in the treatment of patients with mild acute rhinosinusitis. Methods. The study included 85 patients (49 women, 36 men) aged 18 to 56 years (mean age 34.5±6.2 years) with a diagnosis of mild ABR, confirmed by clinical and anamnestic data and laboratory and instrumental research methods. Depending on the tactics of treatment, the patients were randomized into 2 groups. In the main group, the treatment regimen included the use of Sinuforte, 1 dose (1.3 mg) once a day as an intranasal spray for 7 days. In the comparison group, patients used only irrigation of the nasal cavity in combination with decongestants for 7 days. The effectiveness of the treatment was assessed on 3rd and 7th days and was determined by the degree of decrease in subjective and objective symptoms of ABR according to a 10-point system using a visual analogue scale (VAS), mucociliary clearance rate (saccharin test) and dynamics of the X-ray pattern. Results. According to the results obtained, the severity of subjective and objective symptoms of ABR presented in points on the 7th day was significantly lower in the main group. The dynamics of a decrease in the radiographic signs of rhinosinusitis and an improvement in mucociliary clearance in the main group were similar, which was expressed in the achievement of statistical significance between the groups according to these indicators by the end of the study (p<0.05). Conclusion. The results of the study confirm the high efficacy and safety of monotherapy with Sinuforte in patients with mild ABR compared to the treatment regimen using topical decongestants and irrigation therapy. Such a tactic of treatment is characterized by the absence of undesirable effects and allow to avoid the appointment of antibacterial drugs.

Texto integral

Acesso é fechado

Sobre autores

A. Ovchinnikov

A.I. Evdokimov Moscow State University of Medicine and Dentistry

Department of Otorhinolaryngology Moscow, Russia

M. Edzhe

A.I. Evdokimov Moscow State University of Medicine and Dentistry

Email: ayam75@mail.ru
Cand. Sci. (Med.), Department of Otorhinolaryngology 20, build. 1, Delegatskaya str., Moscow 127473, Russian Federation

Bibliografia

  1. Fokkens W.J., Lund V.J., Hopkins C., et a!., European Position Paper on Rhinosinusitis and Nasal Polyps. Rhinol. 2020;50;23:1-299. Doi: 10.4193/ Rhin20.600.
  2. Овчинников А.Ю., Эдже М.А., Хон Е.М. и др. Острый риносинусит: основные заблуждения и возможности стандартизированной фитотерапии. Медицинский совет. 2016;(6):28-31.
  3. Libman H, Brockmeyer D.M., Gold H.S Should we prescribe antibiotics to this patient with persistent upper respiratory symptoms? Grand Rounds Discussion from Beth Israel Deaconess Medical Center. Ann Int Med. 2017;(3):201-8. Doi: 10.732 6/M16-2766.
  4. Passali D, Spinosi M.C., Crisanti A., Bellussi L.M. Momethasone furoate nasal spray: a systematic review. Multidiscipl Resp. Med. 2016;1:18. doi: 10.1186/s40248-016-0054-3.
  5. Назарочкин Ю.В., Назарочкина О.В. Способы оценки состояния полости носа и околоносовых пазух в консервативном лечении больных рино-синуситами препаратами растительного происхождения. Лечащий врач. 2019;11:43-7)]. doi: 10.26295/OS.2019.70.47.011.
  6. Baars E.W., van Zoen E.B., Breitkreuz Th., et al. The Contribution of Complementary and Alternative Medicine to Reduce Antibiotic Use: A Narrative Review of Health Concepts, Prevention, and Treatment Strategies. Evid. Based Complement Alternat. Med. 2019:5365608. Published on-line 2019 Feb 3. doi: 10.1155/2019/5365608.
  7. Казначеева О.Д., Герасименко А.С. Методология поиска новых биологически активных фармакологических веществ с рецепторной активностью. Международный журнал прикладных и фундаментальных исследований. 2016;8-4:522-25.
  8. Jurkiewicz D. Hassmann-Poznanska E., Kazmierczak H., et al. Lyophilized Cyclamen M.A. Edzhe. Editing - A.Yu. Ovchinnikov, M.A. Edzhe europaeum tuber extract in the treatment of hinosinusitis. Otolaryngol Pol. 2016;70(1):1-9. doi: 10.5604/00306657.1195609.
  9. Pietruszewska W., Baranska М., Wielgat J. Place of phytotherapy in the treatment of acute infections of upper respiratory tract and upper gastrointestinal tract. Otolaryngol Pol. 2018;72(4):42-50. doi: 10.5604/01.3001.0012.2833.
  10. Fernandez-Campos F., Clares B., Rodrfguez-Lagunas M.J., et al. Ex-Vivo and In-Vivo Assessment of Cyclamen europaeum Extract After Nasal Administration. Pharmaceutics. 2019;11(9). doi: 10.3390/pharmaceutics11090426.
  11. Evseenko V.A., Kolosova N.P, Gudymo A.S., et al. Intranasal immunization of guinea pig with trivalent influenza antigen adjuvanted by Cyclamen europaeum tubers extract. Arch Virol. 2019;164(1):243-47. doi: 10.1007/s00705-018-4023-3.
  12. Shafiei M. Abdi-Ali A., Shahcheraghi F., et al. Analysis of Pseudomonas aeruginosa PAO1 Biofilm Protein Profile After Exposure to n-Butanolic Cyclamen coum Extract Alone and in Combination with Ciprofloxacin. Appl Biochem Biotechnol. 2017;182(4):1444-57. doi: 10.1007/s12010-017-2409-4.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Bionika Media, 2020

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies